UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Number of items: 204.

Article

Ardeshna, KM; Addison, IE; Pizzey, AR; Linch, DC; Devereux, S; Khwaja, A; (1999) P38 stress-activated protein kinase activity is required for the lipopolysaccharide-induced maturation of monocyte-derived dendritic cells. BRIT J HAEMATOL , 105 33 - 33.

Ardeshna, KM; Linch, DC; Devereux, S; Khwaja, A; (1999) p38 stress-activated protein kinase and NF-kappa B activity are required for lipopolysaccharide-induced maturation of monocyte-derived dendritic cells. BLOOD , 94 (10) 214A - 214A.

Ardeshna, KM; Pizzey, AR; Thomas, NSB; Linch, DC; Devereux, S; (1999) Proliferative capacity and susceptibility to retroviral transduction of CD34 and monocyte derived dendritic cells. BRIT J HAEMATOL , 105 29 - 29.

Backos, M; Rai, R; Baxter, N; Chilcott, IT; Cohen, H; Regan, L; (1999) Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol , 106 (2) pp. 102-107. 10.1111/j.1471-0528.1999.tb08208.x.

Bodmer, JG; Marsh, SG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Terasaki, PI; + view all (1999) Nomenclature for factors of the HLA system, 1998. Eur J Immunogenet , 26 (2-3) pp. 81-116.

Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Terasaki, PI; + view all (1999) Nomenclature for Factors of the HLA System, 1998. HUMAN IMMUNOLOGY , 60 (4) pp. 361-395.

Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... P, I; + view all (1999) Nomenclature for factors of the HLA system, 1998. Vox Sanguinis , 77 pp. 164-191.

Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... P, I; + view all (1999) Nomenclature for factors of the HLA system, 1998. Tissue Antigens , 53 pp. 407-446.

Borthwick, NJ; Wickremasinghe, RG; Lewin, J; Fairbanks, L; Bofill, M; (1999) Activation associated necrosis in HIV infection. The Journal of Infectious Diseases , 179 pp. 352-360.

Borthwick, NJ; Wickremasinghe, RG; Lewin, J; Fairbanks, LD; Bofill, M; (1999) Activation-associated necrosis in human immunodeficiency virus infection. J INFECT DIS , 179 (2) 352 - 360.

Campbell, PJ; Tirvengadum, MA; Pickering, W; Cohen, H; Ryan, KE; (1999) HEPTEST: a suitable method for monitoring heparin during pregnancy. Clin Lab Haematol , 21 (3) pp. 193-199.

Cardigan, RA; Crook, M; Mackie, IJ; Machin, SJ; (1999) Increased levels of activated factor XII (FXIIa) in hyperlipidaemia. THROMB HAEMOSTASIS 729 - 729.

Cardigan, RA; McGloin, H; Mackie, IJ; Machin, SJ; Singer, M; (1999) Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration. Kidney International , 55 (4) pp. 1568-1574.

Cardigan, RA; McGloin, H; Mackie, IJ; Machin, SJ; Singer, M; (1999) Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration. KIDNEY INT , 55 (4) 1568 - 1574.

Chakrabarti, S; Steven, N; Collingham, K; Cassellas, SA; Pillay, D; Kaur, N; Hale, G; ... Milligan, DW; + view all (1999) Viral reactivation and immune reconstitution following Campath 1H and fludarabine based non-myeloablative conditioning for allogeneic stem cell transplantation compared to Campath-based T cell depletion regimens: A preliminary report. BLOOD , 94 (10) 153A - 153A.

Chakraverty, RK; Hickson, ID; (1999) Defending genome integrity during DNA replication: a proposed role for RecQ family helicases. BIOESSAYS , 21 (4) pp. 286-294.

Chitolie, A; Mackie, IJ; Lawrie, AS; Donohue, S; Cohen, H; Machin, SJ; (1999) Evidence of ongoing thrombin generation in patients with prothrombin G -> A 20210 mutation. THROMB HAEMOSTASIS 551 - 552.

Corell, A; Pay, AL; Arguello, JR; Borton, M; Dunne, C; Madrigal, JA; Marsh, SGE; (1999) RSCA (reference strand mediated conformation analysis) resolves HLA-DRB1*04 typing ambiguities where other molecular techniques fail. BLOOD , 94 (10) 318B-318B.

Cox, ST; Arguello, JR; Marsh, SGE; Lau, M; Kwan, PL; Madrigal, JA; Little, AM; (1999) Sequence of HLA-A*6808. TISSUE ANTIGENS , 53 (6) pp. 597-600. 10.1034/j.1399-0039.1999.530614.x.

Cox, ST; Marsh, SGE; Scott, I; Clayton, J; Arguello, JR; McWhinnie, AJ; Prokupek, B; ... Little, AM; + view all (1999) HLA-A, -B, -C polymorphism in a UK Ashkenazi Jewish potential bone marrow donor population. TISSUE ANTIGENS , 53 (1) pp. 41-50. 10.1034/j.1399-0039.1999.530105.x.

Cullen, M; Hancock, BW; Gregory, WM; Hudson, GV; Burton, A; Selby, P; Maclennan, KA; ... Linch, DC; + view all (1999) Ch1VPP/PABIOE is superior to PABIOE: Interim results of the British national lymphoma investigation/central lymphoma group randomised trial in advanced Hodgkin's disease. BRIT J CANCER , 80 18 - 18.

D'Sa, S; Verfuerth, S; Vyas, P; Langabeer, S; Perry, A; Peniket, A; Mackinnon, S; (1999) Early PCR-negativity after allogeneic BMT in adults with t(4;11) ALL in the absence of acute or chronic GVHD. BONE MARROW TRANSPL , 23 (7) 695 - 696.

Dattani, MT; Martinez-Barbera, JP; Thomas, PQ; Brickman, JM; Gupta, R; Wales, JKH; Hindmarsh, PC; ... Robinson, ICAF; + view all (1999) HESX1: a novel gene implicated in a familial form of septo-optic dysplasia. ACTA PAEDIATRICA , 88 49 - 54.

Devereux, S; Corney, C; Macdonald, C; Watts, M; Ward, M; Bank, A; Linch, DC; (1999) Multi-drug resistance (MDR-1) gene transfer in patients with poor prognosis lymphoma undergoing high dose therapy and CD34 selected peripheral blood stem cell transplantation (PBSCT). BONE MARROW TRANSPL , 23 S85 - S85.

Donohoe, S; Geary, M; Kingdom, JCP; Jauniaux, E; Purdy, G; Mackie, IJ; (1999) Maternal cardiolipin, beta(2)-glycoprotein-I and prothrombin antibody expression in high-risk pregnancies with bilateral abnormal uterine artery Doppler waveforms. ULTRASOUND OBST GYN , 13 (5) 317 - 322.

Donohoe, S; Kingdom, J; Mackie, I; Jauniaux, E; Machin, S; (1999) beta(2)GPI and Annexin V in normal and APS villous placenta. BRIT J HAEMATOL , 105 28 - 28.

Donohoe, S; Kingdom, JCP; Mackie, IJ; (1999) Affinity purified human antiphospholipid antibodies bind normal term placenta. LUPUS , 8 (7) 525 - 531.

Donohoe, S; Mackie, I; Kingdom, J; Jauniaux, E; Machin, S; (1999) Placental expression of beta(2)GPI and annexin V in normal and APS pregnancies. THROMB HAEMOSTASIS 66 - 66.

Ellis, BL; Sampson, CB; Abeysinghe, RD; Porter, JB; Hider, RC; (1999) 6-alkoxymethyl-3-hydroxy-4H-pyranones: potential ligands for cell-labelling with indium. EUROPEAN JOURNAL OF NUCLEAR MEDICINE , 26 (11) pp. 1400-1406. 10.1007/s002590050471.

Fierabracci, A; Hammond, L; Lowdell, M; Chiovato, L; Goode, AW; Bottazzo, GF; Mirakian, R; (1999) The effect of staphylococcal enterotoxin B on thyrocyte HLA molecule expression. JOURNAL OF AUTOIMMUNITY , 12 (4) pp. 305-314. 10.1006/jaut.1999.0279.

Fischer, G; Arguello, JR; Perez-Rodriguez, M; Cox, ST; McWhinnie, A; Marsh, SGE; Madrigal, JA; (1999) Novel intronic variants of MICB (MHC class I chain-related gene B). EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (6) pp. 399-404. 10.1046/j.1365-2370.1999.00182.x.

Fischer, G; Perez-Rodriguez, M; Arguello, JR; McWhinnie, A; Marsh, SGE; Travers, PJ; Madrigal, JA; (1999) Associations of MICB with MICA and HLA-B - Implications for the development of graft-versus-host-disease? BLOOD , 94 (10) 367B-367B.

Gale, RE; (1999) Evaluation of clonality in myeloid stem-cell disorders. SEMIN HEMATOL , 36 (4) 361 - 372.

Gale, RE; Forbes, LV; Pizzey, A; Pouwels, K; Linch, DC; (1999) A leukemia-associated mutation in the G-CSF receptor implies a role for the transmembrane domain in receptor activation. BLOOD , 94 (10) 45A - 45A.

Gardiner, C; Harrison, P; Chavda, N; Mackie, IJ; Machin, SJ; (1999) Platelet activation responses in vitro to human mast cell activation. BRIT J HAEMATOL , 106 (1) 208 - 215.

Gardiner, C; Harrison, P; Chavda, N; Mackie, IJ; Machin, SJ; (1999) Platelet aggregation in response to in vitro human mast cell activation. THROMB HAEMOSTASIS 461 - 461.

Gardiner, C; Mackie, IJ; Machin, S; Malia, RG; Jones, DW; Winter, M; Taberner, D; ... Greaves, M; + view all (1999) The impact of different DRVVT calculation methods on lupus anticoagulant testing. British Journal of Haematology , 105 p. 7.

Gardiner, C; Mackie, IJ; Machin, SJ; Taberner, D; Leeming, D; Malia, RG; Jones, DW; ... Greaves, M; + view all (1999) Modification of DRVVT calculation methods improves the specificity of lupus anticoagulants. THROMB HAEMOSTASIS 587 - 587.

Gari, M; Goodeve, A; Wilson, G; Winship, P; Langabeer, S; Linch, D; Vandenberghe, E; ... Reilly, J; + view all (1999) c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 105 (4) pp. 894-900. 10.1046/j.1365-2141.1999.01449.x.

Gooding, RP; Bybee, A; Cooke, F; Little, A; Marsh, SGE; Coelho, E; Gupta, D; ... Apperley, JF; + view all (1999) Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia. BRITISH JOURNAL OF HAEMATOLOGY , 106 (3) pp. 669-681. 10.1046/j.1365-2141.1999.01602.x.

Gosriwatana, I; Loreal, O; Lu, S; Brissot, P; Porter, J; Hider, RC; (1999) Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. ANAL BIOCHEM , 273 (2) 212 - 220.

Goulis, J; Chau, TN; Jordan, S; Mehta, AB; Watkinson, A; Rolles, K; Burroughs, AK; (1999) Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut , 44 (5) pp. 754-758. 10.1136/gut.44.5.754.

Gray, E; Mackie, I; Greaves, M; (1999) Calibration of the 1st British reference plasmas panel for lupus anticoagulants. BRIT J HAEMATOL , 105 97 - 97.

Gray, E; Mackie, I; Greaves, M; (1999) A strategy for improving the quality of lupus anticoagulant testing: Establishment of the 1st British Reference Plasmas Panel for Lupus Anticoagulant. THROMB HAEMOSTASIS 67 - 67.

Griffioen, A; Sabin, CA; Devereux, H; Yee, TT; Lee, CA; (1999) Natural history of hepatitis C virus in a cohort of individuals with clotting factor disorders treated with unsterilised clotting concentrates. THROMB HAEMOSTASIS 475 - 476.

Griffioen, A; Sabin, CA; Devereux, H; Yee, TT; Lee, CA; (1999) Natural history of hepatitis C virus in a cohort of individuals with clotting factor disorders treated with unsterilised clotting concentrates. BRIT J HAEMATOL , 105 50 - 50.

Gupta, R; Abdalla, SH; Bain, BJ; (1999) Thrombocytosis with sideroblastic erythropoiesis: a mixed myeloproliferative myelodysplastic syndrome. Leuk Lymphoma , 34 (5-6) pp. 615-619. 10.3109/10428199909058492.

Hamdulay, SS; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; (1999) Differential expression of the alternatively spliced STAT-1 alpha and beta mRNA and its products in B-CLL and tonsillar B-cells. BRIT J HAEMATOL , 105 86 - 86.

Harrison, CN; Gale, RE; Machin, SJ; Linch, DC; (1999) A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. BLOOD , 93 (2) 417 - 424.

Harrison, CN; Gale, RE; Mire-Sluis, A; Machin, SJ; Linch, DC; (1999) Essential thrombocythaemia with polyclonal haemopoiesis is not due to disruption in levels of interleukins-6,-11, thrombopoietin, or transforming growth factor beta 1 levels. BLOOD , 94 (10) 112A - 112A.

Harrison, CN; Gale, RE; Pezella, F; Mire-Sluis, A; Machin, SJ; Linch, DC; (1999) Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. British Journal of Haematology , 107 (1) pp. 139-147. 10.1046/j.1365-2141.1999.01667.x.

Harrison, CN; Gale, RE; Pezella, F; Mire-Sluis, A; Machin, SJ; Linch, DC; (1999) Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. BRIT J HAEMATOL , 107 (1) 139 - 147.

Harrison, CN; Gale, RE; Pezzella, F; Mire-Sluis, A; Machin, SJ; Linch, DC; (1999) Platelet c-mpl expression and plasma thrombopoietin levels are dysregulated in patients with thrombocytosis; regardless of clonal status. British Journal of Haematology , 107 pp. 139-147.

Harrison, CN; Gregory, W; Hudson, GV; Devereux, S; Goldstone, AH; Hancock, B; Winfield, D; ... Linch, DC; + view all (1999) High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. BRIT J CANCER , 81 (3) 476 - 483.

Harrison, P; Robinson, M; Khair, K; Liesner, R; Carr, P; Criddle, S; Mackie, I; (1999) The PFA-100(R) - A potential screening tool for the assessment of platelet dysfunction. THROMB HAEMOSTASIS 743 - 743.

Harrison, P; Robinson, MSC; Mackie, IJ; Joseph, J; McDonald, SJ; Liesner, R; Savidge, GF; ... Machin, SJ; + view all (1999) Performance of the platelet function analyser PFA-100 (R) in testing abnormalities of primary haemostasis. BLOOD COAGUL FIBRIN , 10 (1) 25 - 31.

Harrison, P; Robinson, MSC; Mackie, IJ; Joseph, J; McDonald, SJ; Liesner, R; Savidge, GF; ... Machin, SJ; + view all (1999) Performance of the platelet function analyser PFA-100® in testing abnormalities of primary haemostasis. Blood Coagulation and Fibrinolysis , 10 (1) pp. 25-31.

Haynes, AP; Kottiridis, P; Byrne, JL; Goldstone, A; Russell, NH; Linch, DC; McKinnon, S; (1999) Results of allogeneic transplantation for lymphoma - A report on 41 patients. BRIT J HAEMATOL , 105 87 - 87.

Hennesey, BJ; Mehta, AB; Kibbler, C; Hoffbrand, AV; (1999) Case Report: Candida glabrata fungal ball in the oesophagus. CME Bulletin Haematology , 2 pp. 100-101.

Hernandez, D; Fisher, EMC; (1999) Mouse autosomal trisomy - two’s company, three’s a crowd. Trends in Genetics , 15 pp. 241-247.

Hernandez, D; Mee, PJ; Martin, JE; Tybulewicz, VLJ; Fisher, EMC; (1999) Transchromosomal mouse embryonic stem cell lines that contain a freely segregating whole or partial human chromosome 21. Human Molecular Genetics , 8 (5) pp. 923-933.

Hillmen, P; Richards, SJ; Baker, AJ; Gale, RE; Rawstron, AC; Crawford, DH; Lalloz, MRA; (1999) Congenital paroxysmal nocturnal haemoglobinuria. BRIT J HAEMATOL , 105 64 - 64.

Holmes, ZR; Regan, L; Chilcott, I; Cohen, H; (1999) The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. BRIT J HAEMATOL , 105 (1) 98 - 101.

Ings, SJ; Schey, S; Hancock, B; Watts, MJ; Vandenberghe, E; Goldstone, AH; Elston, T; ... Linch, DC; + view all (1999) Results of a BNLI randomized trial of G-CSF dose after cyclophosphamide 1.5g/m(2) for progenitor cell mobilization. BLOOD , 94 (10) 666A - 666A.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Hoffbrand, AV; Ganeshaguru, K; (1999) The putative role of Fas and caspase 8 in the killing of B-CLL cells by cytotoxic drugs and radiation. BLOOD , 94 (10) 310A - 310A.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Hoffbrand, AV; Ganeshaguru, K; (1999) The putative role of induced Fas expression in the killing of B-CLL cells by DNA damaging agents. BRIT J HAEMATOL , 105 90 - 90.

Jones, DW; Joseph, JE; Donohoe, S; Mackie, IJ; Gallimore, MJ; Winter, M; (1999) Factor XII antibodies in patients with phospholipid antibodies: Are they predictors of thrombotic risk? THROMB HAEMOSTASIS 66 - 67.

Joseph, JE; Harrison, P; Mackie, IJ; Machin, SJ; (1999) Platelet activation and platelet-leukocyte complexes in the primary antiphospholipid syndrome (PAPS) and systemic lupus erythematosus (SLE). THROMB HAEMOSTASIS 68 - 69.

Joseph, JE; Mackie, IJ; Harrison, P; Machin, SJ; (1999) Increased thrombin generation in patients with the primary antiphospholipid syndrome. BRIT J HAEMATOL , 105 44 - 44.

Khwaja, A; (1999) Akt is more than just a Bad kinase. Nature , 401 (6748) pp. 33-34. 10.1038/43354.

Khwaja, A; (1999) Apoptosis - Akt is more than just a Bad kinase. NATURE , 401 (6748) 33 - 34.

Khwaja, A; Hassan, R; Tatton, EL; Watts, M; Linch, DC; (1999) Inhibition of myeloid cell apoptosis by G-CSF and GM-CSF involves different signal transduction pathways depending on the stage of differentiation. BRIT J HAEMATOL , 105 102 - 102.

Khwaja, A; Tatton, L; (1999) Caspase-mediated proteolysis and activation of protein kinase C delta plays a central role in neutrophil apoptosis. BLOOD , 94 (1) 291 - 301.

Khwaja, A; Tatton, L; (1999) Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J BIOL CHEM , 274 (51) 36817 - 36823. Gold open access

Koh, MBC; Lowdell, MW; Prentice, HG; (1999) The GvH reaction: The 'cytokine storm' and its effect on lymphocyte alloreactive responses. BRIT J HAEMATOL , 105 60 - 60.

Koh, MBC; Prentice, HG; Corbo, M; Cotter, FE; Morgan, M; Ravell, P; Lowdell, MW; (1999) Establishment of the NOD/SCID mouse as a model for allogeneic GvHD. BLOOD , 94 (10) 330B - 330B.

Koh, MBC; Prentice, HG; Corbo, M; Cotter, FE; Morgan, M; Ravell, P; Lowdell, MW; (1999) Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in a NOD/SCID mouse model. BLOOD , 94 (10) 330B - 330B.

Koh, MBC; Prentice, HG; Lowdell, MW; (1999) Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis. BONE MARROW TRANSPL , 23 (10) 1071 - 1079.

Kottaridis, PD; Chakraverty, R; Milligan, DW; Chakrabarti, S; Robinson, S; Chopra, R; Pettengell, R; ... Mackinnon, S; + view all (1999) A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy. BLOOD , 94 (10) 348A - 348A.

Kottaridis, PD; Ketley, N; Peggs, K; Chakraverty, R; Ralleigh, G; Shaw, P; Pezzella, F; ... Mackinnon, S; + view all (1999) An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and responding to donor lymphocyte infusion. BONE MARROW TRANSPL , 24 (7) 807 - 809.

Kottaridis, PD; Rees, H; Smith, G; Garner, SF; Perry, AR; Peniket, AJ; Goldstone, AH; ... Ouwehand, WH; + view all (1999) A fatal case of autoimmune thrombocytopenia with an IgM anti-GPIb/IX following one antigen mismatched unrelated donor bone marrow transplantation. BONE MARROW TRANSPL , 23 (7) 739 - 741.

Lam, EWF; Glassford, J; van der Sman, J; Banerji, L; Pizzey, AR; Thomas, NSB; Klaus, GGB; (1999) Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors. EUR J IMMUNOL , 29 (10) 3380 - 3389.

Langabeer, SE; Gale, RE; Mackinnon, S; Linch, DC; (1999) Transcription mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. BLOOD , 94 (10) 283A - 283A.

Langabeer, SE; Grimwade, D; Walker, H; Burnett, AK; Goldstone, AH; Linch, DC; (1999) EV1-1 expression in acute promyelocytic leukaemia. BRIT J HAEMATOL , 105 74 - 74.

Lawrie, AS; Mackie, IJ; Purdy, G; Kitchen, S; Howarth, D; Martin, J; Rigsby, P; ... BCSH fibrinogen working party Med, ; + view all (1999) A comparative study of commercial fibrinogen reference preparations, Clauss and PT-derived fibrinogen assay reagents. THROMB HAEMOSTASIS 605 - 605.

Lawrie, AS; Mackie, IJ; Purdy, G; Machin, SJ; (1999) The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers. THROMB HAEMOSTASIS , 81 (5) 758 - 762.

Linch, DC; Goldstone, AH; (1999) High-dose therapy for Hodgkin's disease. BRIT J HAEMATOL , 107 (4) 685 - 690.

Lowdell, MW; Craston, R; Prentice, HG; (1999) Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following alpha interferon treatment. BRIT J HAEMATOL , 105 78 - 78.

Lowdell, MW; Craston, R; Prentice, HG; (1999) Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following interferon-alpha treatment. CYTOKINES CELL MOL T , 5 (2) 119 - 121.

Lowdell, MW; Wood, ME; Corbo, M; Hennessy, B; Cotter, FE; Craston, R; Prentice, HG; (1999) AML-reactive autologous NK cells predict patient survival and can prevent leukaemia outgrowth in an animal model. BLOOD , 94 (10) 596A - 596A.

Lowdell, MW; Wood, ME; Craston, R; Prentice, HG; (1999) Measurement of autologous immunity to leukaemia can predict maintenance of complete remission at two years. BRIT J HAEMATOL , 105 59 - 59.

Mackinnon, S; Kottaridis, P; Perry, A; Chakrabarti, S; Milligan, DW; Pettengell, R; Chopra, R; ... Goldstone, AH; + view all (1999) Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation. BRIT J HAEMATOL , 105 31 - 31.

Marsh, SG; (1999) Nomenclature for Factors of the HLA System, update September 1998. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (1) pp. 88-89.

Marsh, SG; (1999) Nomenclature for Factors of the HLA system, update August 1998. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (1) 87-.

Marsh, SG; (1999) Nomenclature for factors of the HLA System, update December 1998. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (3) 271-.

Marsh, SG; (1999) Nomenclature for factors of the HLA System, update November 1998. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (3) pp. 269-270.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update April 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (2) pp. 209-211.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update April 1999. WHO Nomenclature Committee for factors of the HLA system. Hum Immunol , 60 (9) pp. 918-919.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update February 1999. Marsh for the WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (1) pp. 108-109.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update February 1999. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (5) 451-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update January 1999. Marsh for the WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (1) pp. 106-107.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update January 1999. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (5) 450-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update July/August 1999. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (11) 1156-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update July/August 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (5) pp. 531-532.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update June 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (3) pp. 322-324.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update June 1999. WHO Nomenclature Committee for Factors of the HLA system. Hum Immunol , 60 (10) pp. 1011-1012.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update March 1999. Marsh for the WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (1) pp. 110-111.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update March 1999. WHO Nomenclature Committee for factors of the HLA system. Hum Immunol , 60 (7) 627-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update May 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (2) 212-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update May 1999. WHO Nomenclature Committee for factors of the HLA system. Hum Immunol , 60 (9) 920-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update October 1998. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (3) 268-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update September 1999. WHO nomenclature committee for factors of the HLA system. Hum Immunol , 60 (12) 1310-.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update April 1999. HUMAN IMMUNOLOGY , 60 (9) pp. 918-919.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update April 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (5) pp. 379-380. 10.1046/j.1365-2370.1999.00179.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update August 1998. HUMAN IMMUNOLOGY , 60 (1) p. 87.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update December 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (2-3) p. 247.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update February 1999. HUMAN IMMUNOLOGY , 60 (5) p. 451.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update February 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (4) p. 317. 10.1046/j.1365-2370.1999.00171.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update January 1999. HUMAN IMMUNOLOGY , 60 (5) p. 450.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update January 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (4) p. 315. 10.1046/j.1365-2370.1999.00170.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update July/August 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (6) p. 427. 10.1046/j.1365-2370.1999.00195.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update June 1999. TISSUE ANTIGENS , 54 (3) pp. 322-324.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update June 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (5) pp. 383-384. 10.1046/j.1365-2370.1999.00181.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update June 1999 - Compiled by Steven G. E. Marsh for the WHO Nomenclature Committee for Factors of the HLA System. HUMAN IMMUNOLOGY , 60 (10) pp. 1011-1012.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update March 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (4) p. 319. 10.1046/j.1365-2370.1999.00172.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update May 1999. HUMAN IMMUNOLOGY , 60 (9) p. 920.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update May 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (5) p. 381. 10.1046/j.1365-2370.1999.00180.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update November 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (2-3) pp. 245-246.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update October 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (2-3) p. 243.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update September 1988. HUMAN IMMUNOLOGY , 60 (1) pp. 88-89.

Mendoza-Rincon, J; Arguello, JR; Perez-Rodriguez, M; McWhinnie, A; Marsh, SGE; Fischer, G; Madrigal, JA; (1999) Characterization of the MICA polymorphism by sequence-specific oligonucleotide probing. IMMUNOGENETICS , 49 (6) pp. 471-478. 10.1007/s002510050523.

Mengubas, K; Fahey, AA; Lewin, J; Mehta, AB; Hoffbrand, AV; Wickremasinghe, RG; (1999) Killing of T lymphocytes by synthetic ceramide is by a nonapoptotic mechanism and is abrogated following mitogenic activation. EXP CELL RES , 249 (1) 116 - 122.

Mengubas, K; Riordan, FA; Bravery, CA; Lewin, J; Owens, DL; Mehta, AB; Hoffbrand, AV; (1999) Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism. ONCOGENE , 18 (15) 2499 - 2506.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (1999) Effect of adhesion molecule expression on survival of F-cells and F-reticulocytes in sickle cell disorders. BRIT J HAEMATOL , 105 72 - 72.

Mundee, Y; Porter, JB; (1999) Contribution of adhesion molecule expression and F(+)cell production to red cell survival in sickle cell disorders with and without hydroxyurea therapy. BLOOD , 94 (10) 421A - 421A.

Nagral, A; Mehta, AB; Gomes, ATB; Ellis, G; Jackson, BFA; Sabin, CA; McIntyre, N; (1999) Serum soluble transferrin receptor in the diagnosis of iron deficiency in chronic liver disease. CLINICAL AND LABORATORY HAEMATOLOGY , 21 (2) pp. 93-97. 10.1046/j.1365-2257.1999.00202.x.

Nathwani, AC; Persons, DA; Stevenson, SC; Frare, P; McClelland, A; Nienhuis, AW; Vanin, EF; (1999) Adenovirus-mediated expression of the murine ecotropic receptor facilitates transduction of human hematopoietic cells with an ecotropic retroviral vector. GENE THERAPY , 6 (8) pp. 1456-1468. 10.1038/sj.gt.3300974.

Ng, TTC; Collins, IE; Kanner, SB; Humphries, MJ; Amft, N; Wickremasinghe, RG; D'Cruz, D; ... Morrow, WJW; + view all (1999) Integrin signalling defects in T-lymphocytes in systemic lupus erythematosus. LUPUS , 8 (1) 39 - 51.

Noble, KE; Wickremasinghe, RG; DeCornet, C; Panayiotidis, P; Yong, KL; (1999) Monocytes stimulate expression of the Bcl-2 family mamber ,A1, in endothelia cells and confer protection against apoptosis. The Journal of Immunology , 162 (3) pp. 1376-1383.

Noble, KE; Wickremasinghe, RG; DeCornet, C; Panayiotidis, P; Yong, KL; (1999) Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis. J IMMUNOL , 162 (3) 1376 - 1383.

Orchard, KH; Cooper, M; Mehta, A; Potter, M; Wijdenes, J; Borchardt, P; Quadri, S; ... Prentice, HG; + view all (1999) Targeted radiotherapy for patients with multiple myeloma: Results of pre-clinical evaluation of candidate antibodies. BLOOD , 94 (10) 302B - 302B.

Orchard, KH; Cooper, M; Mehta, A; Potter, M; Wijdenes, J; Borchardt, P; Quadri, S; ... Prentice, HG; + view all (1999) Targeted radiotherapy for patients with multiple myeloma: Results of pre-clinical evaluation of candidate antibodies. Blood , 94 p. 4576.

Pang, KF; Ganeshaguru, K; Hart, SM; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Mehta, AB; (1999) Expression of the multidrug resistance protein gene homologues in B-CLL and AML cells. BLOOD , 94 (10) 280A - 280A.

Pawson, R; Rajan, S; Hazlehurst, G; Dusheiko, G; Miller, R; Hewitt, P; Mehta, A; (1999) Hepatitis C Lookback Programme: A single hospital experience. Transfusion Medicine , 9 (3) pp. 189-193. 10.1046/j.1365-3148.1999.00197.x.

Pearce, D; Pizzey, A; Uhr, M; Gordon-Smith, EC; Pettengell, RCP; McGuckin, CP; (1999) Intracellular CD34 progenitor subset analysis. BRITISH JOURNAL OF HAEMATOLOGY , 105 p. 57.

Perez-Rodriguez, M; Arguello, R; Fischer, G; Cox, S; McWhinnie, A; Corell, A; Travers, PJ; ... Madrigal, A; + view all (1999) Does the polymorphism of MICA influence bone marrow transplant complications? BLOOD , 94 (10) 393B-393B.

Perry, AR; Peniket, AJ; Watts, MJ; Leverett, D; Goldstone, AH; Linch, DC; (1999) Peripheral blood stem cell versus autologous bone marrow transplantation for Hodgkin's disease: equivalent survival outcome in a single-centre matched-pair analysis. BRIT J HAEMATOL , 105 (1) 280 - 287.

Pollard, Y; Watts, MJ; Grant, D; Chavda, N; Linch, DC; Machin, SJ; (1999) Use of the haemopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells. BRIT J HAEMATOL , 106 (2) 538 - 544.

Porakishvili, N; Roshupkina, T; Jewell, AP; Patterson, K; Yong, K; Lydyard, PM; (1999) Circulating CD4+ cells in patients with B-chronic lymphocytic leukaemia (B-CLL) express perforin (PF) and serine esterase (SE). Immunology , 98 (Suppl) 20-.

Rees, DC; Porter, JB; Clegg, JB; Weatherall, DJ; (1999) Why are hemoglobin F levels increased in HbE/beta thalassemia? BLOOD , 94 (9) 3199 - 3204.

Rege, KP; Bevan, DH; Chitolie, A; Shannon, MS; (1999) Risk factors and thrombosis after airline flight. THROMB HAEMOSTASIS , 81 (6) 995 - 996.

Roberts, PJ; Mollapour, E; Watts, MJ; Linch, DC; (1999) Primitive myeloid cells express high levels of phospholipase A(2) activity in the absence of leukotriene release: Selective regulation by stem cell factor involving the MAP kinase pathway. BLOOD , 94 (4) 1261 - 1272.

Robertson, J; Gale, RE; Linch, DC; Testa, NG; Chopra, R; (1999) Acquired skewed haemopoiesis in the elderly is independent of telomere shortening-implications for stem cell utilisation. BLOOD , 94 (10) 254A - 254A.

Robertson, JD; Gale, R; Wynn, RF; Robinson, SA; Greaves, MJ; Dougal, M; Linch, DC; ... Chopra, R; + view all (1999) Telomere shortening in peripheral blood neutrophils and T cells with age in healthy individuals. BRIT J HAEMATOL , 105 103 - 103.

Robinson, M; Machin, S; Mackie, I; Harrison, P; (1999) In vivo biotinylation studies: Specificity of labelling of reticulated platelets by thiazole orange and mepacrine. THROMB HAEMOSTASIS 826 - 826.

Schreuder, GM; Hurley, CK; Marsh, SG; Lau, M; Maiers, M; Kollman, C; Noreen, H; (1999) The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens , 54 (4) pp. 409-437.

Schreuder, GM; Hurley, CK; Marsh, SG; Lau, M; Maiers, M; Kollman, C; Noreen, H; (1999) The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Hum Immunol , 60 (11) pp. 1157-1181.

Shaw, BE; Potter, MN; Pawson, R; Virchis, AE; Patch, D; Murphy, K; Perry, D; (1999) The use of defibrotide in the management of vascular endothelial complications (VOD/HUS/TTP) of stem cell transplantation. BLOOD , 94 (10) 608A - 608A.

Shoab, SS; Porter, J; Scurr, JH; Coleridge-Smith, PD; (1999) Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease - a prospective study. EUR J VASC ENDOVASC , 17 (4) 313 - 318.

Small, TN; Papadopoulos, EB; Boulad, F; Black, P; Castro-Malaspina, H; Childs, BH; Collins, N; ... O'Reilly, RJ; + view all (1999) Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood , 93 (2) pp. 467-480.

Somervaille, TCP; Kirk, S; Dogan, A; Landon, GV; Mackinnon, S; (1999) Fulminant hepatic failure caused by adenovirus infection following bone marrow transplantation for Hodgkin's disease. BONE MARROW TRANSPL , 24 (1) 99 - 101.

Srichairatanakool, S; Davis, BA; Porter, JB; (1999) Direct chelation of NTBI by desferrioxamine does not occur at clinically relevant rates in plasma. BRIT J HAEMATOL , 105 72 - 72.

Stephenson, JM; Griffioen, A; Woronowski, H; Phillips, AN; Petruckevitch, A; Keenlyside, R; Johnson, AM; ... MRC Collaborative Study HIV Infection Women, ; + view all (1999) Survival and progression of HIV disease in women attending GUM/HIV clinics in Britain and Ireland. SEX TRANSM INFECT , 75 (4) 247 - 252.

Sweetenham, JW; Carella, AM; Taghipour, G; Cunningham, D; Marcus, R; Della Volpe, A; Linch, DC; ... European Grp Blood Marrow Transplantation, ; + view all (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation. J CLIN ONCOL , 17 (10) 3101 - 3109.

Theocharous, P; Lowdell, MW; Jones, AL; Prentice, HG; (1999) Ultrasensitive immunocytochemical and fluorescent detection and characterisation of circulating and micrometastatic tumour cells in patients with breast cancer. BRIT J HAEMATOL , 105 60 - 60.

Tonks, S; Marsh, SG; Bunce, M; Bodmer, JG; (1999) Molecular typing for HLA class I using ARMS-PCR: further developments following the 12th International Histocompatibility Workshop. Tissue Antigens , 53 (2) pp. 175-183.

UK, FCG; (1999) A multicentre study of combination of Fludarabine phospate, cytosine arabinoside and granulocyte-colony stimulator factor (FLAG) in relapsed and refractory acute myeloid leukaemia and de novo RAEB-T. Trends in Onco-Hematology , 7 (2) pp. 27-29.

Vevs, P; Davies, G; Webb, D; Jones, A; Hassan, A; Pagliuca, A; Mufti, GJ; ... Mieli-Vergani, G; + view all (1999) Non-myeloablative preparative regimen in children with severe organ dysfunction undergoing unrelated related donor BMT. BRIT J HAEMATOL , 105 66 - 66.

Veys, PA; Davies, EG; Webb, D; Jones, A; Hassan, A; Pagliuca, A; Mufti, GJ; ... Mieli-Vergani, G; + view all (1999) Non-myeloablative preparative regimen in children with severe organ dysfunction undergoing bone marrow transplantation. PEDIATR RES , 45 (5) 768 - 768.

Vig, S; Chitolie, A; Maurice, E; Boa, F; Bevan, DH; Halliday, A; Dormandy, J; (1999) Thromboelastography as a screen for hypercoagulable states predicts failure of peripheral arterial intervention. BLOOD , 94 (10) 114B - 114B.

Vincent-Lacaze, N; Snyder, RO; Gluzman, R; Bohl, D; Lagarde, C; Danos, O; (1999) Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J Virol , 73 (3) pp. 1949-1955.

Watts, MJ; Ings, SJ; Chavda, N; Mackinnon, S; Devereux, S; Linch, DC; (1999) Evaluation of clinical scale CD34+cell purification devices. BRIT J HAEMATOL , 105 58 - 58.

Watts, MJ; Ings, SJ; Flynn, M; Dodds, D; MacMillan, A; Goldstone, AH; Linch, DC; (1999) Remobilization of poor stem cell mobilizers is clinically worthwhile. BLOOD , 94 (10) 328A - 328A.

Wheadon, H; Roberts, PJ; Watts, MJ; Linch, DC; (1999) Changes in signal transduction downstream from the granulocyte-macrophage colony-stimulating factor receptor during differentiation of primary hemopoietic cells. EXP HEMATOL , 27 (6) 1077 - 1086.

Wickramasinghe, SN; Thein, SL; Srichairatanakool, S; Porter, JB; (1999) Determinants of iron status and bilirubin levels in congenital dyserythropoietic anaemia type I. BRIT J HAEMATOL , 107 (3) 522 - 525.

Wickremasinghe, RG; Ganeshaguru, K; Gordon, M; Parsons, A; Hoffbrand, AV; Prentice, HG; Mehta, AB; (1999) The protein tyrosine kinase inhibitor herbimycin A augments cytotoxic drug-induced apoptosis in B-CLL cells cultured with interleukln-4 or autologous plasma. BRIT J HAEMATOL , 105 86 - 86.

Wickremasinghe, RG; Hoffbrand, AV; (1999) Biochemical and genetic control of apoptosis: Relevance to normal hematopoiesis and hematological malignancies. BLOOD , 93 (11) 3587 - 3600.

Wickremasinghe, RG; Jones, DT; Gordon, M; Hoffbrand, AV; Prentice, HG; Mehta, AB; Ganeshaguru, K; (1999) Autologous plasma mediates survival of B-CLL cells via activation of the Akt protein kinase. BLOOD , 94 (10) 280A - 280A.

Wickremasinghe, RG; Jones, DT; Hoffbrand, AV; Prentice, HG; Mehta, AB; Ganeshaguru, K; (1999) Caspase 3 activation in the absence of cytoplasmic cytochrome C elevation during apoptotic death of B-CLL cells. BLOOD , 94 (10) 310A - 310A.

Wiener, E; Allen, D; Porter, RJ; Wickramasinghe, SN; Porter, JB; Chinprasertsuk, S; Siripanyaphinyo, U; ... Wanachiwanawin, W; + view all (1999) Role of Fc gamma RI (CD64) in erythrocyte elimination and its up-regulation in thalassaemia. BRIT J HAEMATOL , 106 (4) 923 - 930.

Williamson, LM; Lowe, S; Love, EM; Cohen, H; Soldan, K; McClelland, DBL; Skacel, P; (1999) Serious hazards of transfusion (SHOT) initiative: Analysis of the first two annual reports. British Medical Journal , 318 (7201) pp. 16-19.

Williamson, LM; Lowe, S; Love, EM; Cohen, H; Soldan, K; McClelland, DBL; Skacel, P; (1999) Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BRIT MED J , 319 (7201) 16 - 19.

Wittke, B; Mackie, IJ; Machin, SJ; Timm, U; Zell, M; Goggin, T; (1999) Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers. BRIT J CLIN PHARMACO , 47 (5) 521 - 530.

Yong, K; Fahey, A; Reeve, L; Nicholls, C; Thomas, NSB; Pizzey, A; Ings, SJ; ... Linch, DC; + view all (1999) Cord blood progenitor cells have greater transendothelial migratory activity and increased responses to SDF-1 and MIP-3 beta compared with mobilized adult progenitor cells. BRIT J HAEMATOL , 107 (2) 441 - 449.

Yong, K; Fahey, A; Thomas, NSB; Inge, S; Watts, M; Linch, DC; (1999) Transendothelial migration of CD34(+) cells requires growth factor activation and occurs predominantly in G(0)/G(1) phase of the cell cycle. BLOOD , 94 (10) 40A - 40A.

Book chapter

Wickremasinghe, RG; Hoffbrand, AV; (1999) Molecular basis of leukaemia and lymphoma. In: Provan, D and Gribben, J, (eds.) Molecular Haematology. (pp. 25-41). Blackwell Science: Oxford.

Yong, KL; (1999) Blood and its disorders. In: Westwood, OMR, (ed.) The scientific basis for health care. (pp. 417-432). C.V. Mosby

Yong, KL; Jewell, AP; (1999) Diseases of the Central Nervous System. In: Westwood, OMR, (ed.) The scientific basis for health care. (pp. 525-538). C.V. Mosby

Yong, KL; Jewell, AP; (1999) Diseases of the Gut, Liver and Biliary Tract. In: Westwood, OMR, (ed.) The scientific basis for health care. (pp. 461-478). C.V. Mosby

Yong, KL; Jewell, AP; (1999) Diseases of the endocrine system. In: Westwood, OMR, (ed.) The scientific basis for health care. (pp. 479-492). C.V. Mosby

Proceedings paper

Allford, SL; Harrison, P; Cohen, H; Mackie, IJ; Machin, SJ; (1999) Platelet activation in thrombotic thrombocytopenic purpura. In: THROMB HAEMOSTASIS. (pp. 361 - 361). F K SCHATTAUER VERLAG GMBH

Arnold, J; Holmes, Z; Pickering, W; Regan, L; Cohen, H; (1999) Prevalence of anti-beta 2 glycoprotein 1 IgG antibodies in women with recurrent miscarriage. In: THROMB HAEMOSTASIS. (pp. 535 - 536). F K SCHATTAUER VERLAG GMBH

Arnold, J; Holmes, Z; Pickering, W; Regan, L; Cohen, H; (1999) Prevalence of anti-beta 2 glycoprotein 1 IgG antibodies in women with recurrent miscarriage. In: BRIT J HAEMATOL. (pp. 45 - 45). BLACKWELL SCIENCE LTD

Gan, TJ; Bennett-Guerrero, E; Phillips-Bute, B; Wakeling, H; Moskowitz, DM; Olufolabi, Y; Konstadt, SN; ... Hextend Study Grp, ; + view all (1999) Hextend (R), a physiologically balanced plasma expander for large volume use in major surgery: A randomized phase III clinical trial. In: ANESTHESIA AND ANALGESIA. (pp. 992 - 998). LIPPINCOTT WILLIAMS & WILKINS

Holmes, Z; Backos, M; Atoyebi, W; Pickering, W; Regan, L; Cohen, H; (1999) Screening for heritable thrombophilic risk factors in a recurrent miscarriage population. In: THROMB HAEMOSTASIS. (pp. 534 - 535). F K SCHATTAUER VERLAG GMBH

Holmes, Z; Backos, M; Atoyebi, W; Pickering, W; Regan, L; Cohen, H; (1999) Screening for heritable thrombophilic risk factors in a recurrent miscarriage population. In: BRIT J HAEMATOL. (pp. 45 - 45). BLACKWELL SCIENCE LTD

Kottaridis, PD; Peggs, K; Harrison, C; Angus, G; Peniket, A; Miller, B; Devereux, S; ... Goldstone, AH; + view all (1999) Age over 60 is not a barrier for successful autologous stem cell transplantation in selected patients with lymphoma: A single institution's experience in 37 consecutive patients. In: BLOOD. (pp. 170A - 170A). AMER SOC HEMATOLOGY

Peggs, KS; Kottaridis, PD; Preiser, W; McCaig, N; Brink, N; Ward, K; Tedder, R; ... Mackinnon, S; + view all (1999) Molecular monitoring for CMV infection after allogeneic transplantation: Benefits and limitations of PCR directed pre-emptive antiviral therapy. In: BLOOD. (pp. 337A - 337A). AMER SOC HEMATOLOGY

Peggs, KS; Verfuerth, S; Ainsworth, J; Pizzey, A; Moss, PAH; Mackinnon, S; (1999) CMV specific HLA-tetramer sorting of ex-vivo expanded CD8+CTL: Selection of highly restricted clonal populations suitable for adoptive cellular therapy. In: BLOOD. (pp. 395A - 395A). AMER SOC HEMATOLOGY

Verfuerth, S; Peggs, K; Mackinnon, S; (1999) Generation of CMV-specific T cells for adoptive immunotherapy after allogeneic BMT: A novel in vitro culture assay that is free of live virus which uses donor dendritic cells pulsed with CMV antigen. In: BLOOD. (pp. 155A - 155A). AMER SOC HEMATOLOGY

Verfuerth, S; Peggs, KS; Vyas, P; Barnett, L; O'Reilly, RJ; Mackinnon, S; (1999) Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping following T cell depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T cell repertoire. In: BLOOD. (pp. 344A - 345A). AMER SOC HEMATOLOGY

Yung, L; Kottaridis, PD; Peggs, K; Miller, B; McKeag, N; Devereux, S; Goldstone, AH; ... Mackinnon, S; + view all (1999) Older age is not a barrier to successful allogeneic BMT. In: BONE MARROW TRANSPL. (pp. S235 - S235). STOCKTON PRESS

Report

Williamson, LM; Lowe, S; Cohen, H; Love, EM; (1999) The 1997/1998 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Conference item

Allford, SL; Harrison, P; Mackie, IJ; Cohen, H; Machin, SJ; (1999) Platelet activation markers in thrombotic thrombocytopenic purpura. Presented at: UNSPECIFIED.

This list was generated on Sun Aug 18 05:03:39 2019 BST.